AAAAAA
Results:
1-21
|
Results: 21
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Mabro, M
Artru, P
Gilles, V
Lotz, JP
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7), EUR J CANC, 37(8), 2001, pp. 1000-1005
Authors:
Louvet, C
Andre, T
Hammel, P
Selle, F
Landi, B
Cattan, S
Fonck, M
Flesch, M
Colin, P
Balosso, J
Ruszniewski, P
de Gramont, A
Citation: C. Louvet et al., Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine foradvanced pancreatic adenocarcinoma (FOLFUGEM), ANN ONCOL, 12(5), 2001, pp. 675-679
Authors:
Andre, T
Colin, P
Louvet, C
Gamelin, E
Bouche, O
Achille, E
Colbert, N
Boaziz, C
Piedbois, P
Tubiana-Mathieu, N
Boutan-Laroze, A
Flesch, M
Billiau, V
Buyse, M
de Gramont, A
Citation: T. Andre et al., Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminarysafety results, SEMIN ONCOL, 28(1), 2001, pp. 35-40
Authors:
Andre, T
Citation: T. Andre, 'Absentia anima', EUR-REV LIT, 79(870), 2001, pp. 265-266
Authors:
Andre, T
Citation: T. Andre, Le 'Depossede', EUR-REV LIT, 79(870), 2001, pp. 266-267
Authors:
Andre, T
Citation: T. Andre, 'Rembrandt fecit', EUR-REV LIT, 79(870), 2001, pp. 267-267
Authors:
Andre, T
Citation: T. Andre, La 'Peau', EUR-REV LIT, 79(870), 2001, pp. 268-268
Authors:
Andre, T
Louvet, C
Maindrault-Goebel, F
de Gramont, A
Citation: T. Andre et al., Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer, B CANCER, 88, 2001, pp. S20-S25
Authors:
Maindrault-Goebel, F
de Gramont, A
Louvet, C
Andre, T
Carola, E
Gilles, V
Lotz, JP
Tournigand, C
Mabro, M
Molitor, JL
Artru, P
Izrael, V
Krulik, M
Citation: F. Maindrault-goebel et al., Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer, ANN ONCOL, 11(11), 2000, pp. 1477-1483
Authors:
Andre, T
Balosso, J
Louvet, C
Hannoun, L
Houry, S
Huguier, M
Colonna, M
Lotz, JP
De Gramont, A
Bellaiche, A
Parc, R
Touboul, E
Izrael, V
Citation: T. Andre et al., Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: Results of a feasibility study, INT J RAD O, 46(4), 2000, pp. 903-911
Authors:
Andre, T
Kotelevets, L
Vaillant, JC
Coudray, AM
Weber, L
Prevot, S
Parc, R
Gespach, C
Chastre, E
Citation: T. Andre et al., VEGF, VEGF-B, VEGF-C, and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa, INT J CANC, 86(2), 2000, pp. 174-181
Authors:
Maindrault-Goebel, F
Louvet, C
Andre, T
Carola, E
Lotz, JP
Molitor, JL
Garcia, ML
Gilles-Amar, V
Izrael, V
Krulik, M
de Gramont, A
Citation: F. Maindrault-goebel et al., Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6), EUR J CANC, 35(9), 1999, pp. 1338-1342
Authors:
Andre, T
Louvet, C
Maindrault-Goebel, F
Couteau, C
Mabro, M
Lotz, JP
Gilles-Amar, V
Krulik, M
Carola, E
Izrael, V
de Gramont, A
Citation: T. Andre et al., CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer, EUR J CANC, 35(9), 1999, pp. 1343-1347
Authors:
Brienza, S
Bensmaine, MA
Soulie, P
Louvet, C
Gamelin, E
Francois, E
Ducreux, M
Marty, M
Andre, T
de Braud, F
Bleiberg, H
Segal, V
Itzhaki, M
Cvitkovic, E
Citation: S. Brienza et al., Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): Results from the European compassionate-use program, ANN ONCOL, 10(11), 1999, pp. 1311-1316
Authors:
Andre, T
Bensmaine, MA
Louvet, C
Francois, E
Lucas, V
Desseigne, F
Beerblock, K
Bouche, O
Carola, E
Merrouche, Y
Morvan, F
Dupon-Andre, G
de Gramont, A
Citation: T. Andre et al., Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracilinfusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen, J CL ONCOL, 17(11), 1999, pp. 3560-3568
Authors:
Andre, T
Whigham, M
Hendrickson, A
Chambers, S
Citation: T. Andre et al., Competency beliefs, positive affect, and gender stereotypes of elementary students and their parents about science versus other school subjects, J RES SCI T, 36(6), 1999, pp. 719-747
Authors:
Andre, T
Balosso, J
Citation: T. Andre et J. Balosso, Chemotherapy, combined radiochemotherapy and new therapeutic approaches for adenocarcinoma of the pancreas, J CHIR, 136(6), 1999, pp. 309-317
Authors:
Holland, A
Andre, T
Citation: A. Holland et T. Andre, Student characteristics and choice of high school remembrance role, ADOLESCENCE, 34(134), 1999, pp. 315-338
Authors:
Andre, T
Louvet, C
Raymond, E
Tournigand, C
de Gramont, A
Citation: T. Andre et al., Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen, ANN ONCOL, 9(11), 1998, pp. 1251-1253
Authors:
Andre, T
Chastre, E
Kotelevets, L
Vaillant, JC
Louvet, C
Balosso, J
Le Gall, E
Prevot, S
Gespach, C
Citation: T. Andre et al., Tumoral angiogenesis: physiopathology, prognostic value and therapeutical prospects, REV MED IN, 19(12), 1998, pp. 904-913
Authors:
Ducreux, M
Gil-Delgado, M
Andre, T
Ychou, M
de Gramond, A
Khayat, D
Citation: M. Ducreux et al., Combination of irinotecan and other drugs in the treatment of colorectal metastatic cancer, B CANCER, 1998, pp. 43-46
Risultati:
1-21
|